Vor Ort
Merkzettel Warenkorb
Produktbild: Vaccinology

Vaccinology Principles and Practice

239,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

10.08.2012

Herausgeber

D. Huw Davies + weitere

Verlag

John Wiley & Sons

Seitenzahl

560

Maße (L/B/H)

25,4/19,5/3,3 cm

Gewicht

1099 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-4051-8574-5

Beschreibung

Rezension

"Vaccinology provides an invaluable and authoritative resource for clinicians, scientific and medical researchers, lecturers and postdoctoral fellows working in the field of vaccines." ( Sir Read A lot , 10 May 2012)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

10.08.2012

Herausgeber

Verlag

John Wiley & Sons

Seitenzahl

560

Maße (L/B/H)

25,4/19,5/3,3 cm

Gewicht

1099 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-4051-8574-5

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Vaccinology
  • List of Contributors, viii
     
    Preface, xii
     
    Part 1 Introduction
     
    1 Concept and Scope of Modern Vaccines, 3
    D. Huw Davies, Clint S. Schmidt, & Nadeem A. Sheikh
     
    Part 2 Principles of Vaccine Design
     
    2 Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants, 15
    Heather L. Wilson, Scott Napper, George K. Mutwiri, Sylvia van Drunen Littel-van den Hurk, Hugh Townsend, Lorne A. Babiuk, Andrew A. Potter, & Volker Gerdts
     
    3 Antigen Processing and Presentation by MHC Class I, II, and Nonclassical Molecules, 29
    Antony N. Antoniou, Izabela Lenart, David B. Guiliano, & Simon J. Powis
     
    4 Understanding the Mucosal Immune System for Better Mucosal Vaccine Design, 47
    Janine Bilsborough & Joanne L. Viney
     
    5 Immunologic Memory: T Cells in Humans, 61
    Maria Candela Iglesias, Victor Appay, & Arnaud Moris
     
    6 Immunologic Memory: B cells, 79
    F. Eun-Hyung Lee & I ~ naki Sanz
     
    7 Utility of Mouse Models in Vaccine Design and Development, 94
    Catharine M. Bosio, Megan MacLeod, Philippa Marrack, & Ross M. Kedl
     
    8 Utility of Nonhuman Primate Models for Vaccines, 110
    Preston A. Marx, Jr & Alexander F. Voevodin
     
    Part 3 Antigen Discovery
     
    9 Sequence-Based Computational Approaches to Vaccine Discovery and Design, 133
    Darrick Carter
     
    10 Antigen Discovery for Vaccines Using High-throughput Proteomic Screening Technologies, 150
    D. Huw Davies
     
    11 Phage Libraries, 168
    Aaron K. Sato
     
    Part 4 Antigen Engineering
     
    12 Attenuated Bacterial Vaccines, 181
    Richard W. Titball & Helen S. Atkins
     
    13 Virus-like Particles as Antigen Scaffolds, 196
    Bryce Chackerian & John T. Schiller
     
    14 Recombinant MVA vaccines: Optimization, Preclinical, and Product Development, 209
    Yper Hall & Miles W. Carroll
     
    15 Recombinant Adenoviruses for Vaccination, 224
    Nelson Cesar Di Paolo, Dmitry Shayakhmetov, & Andr´e Lieber
     
    16 Recombinant Avipoxviruses, 237
    Michael A. Skinner & Stephen M. Laidlaw
     
    17 Intracellular Facultative Bacterial Vectors for Cancer Immunotherapy, 255
    Patrick Guirnalda, Laurence Wood, Matthew Seavey, & Yvonne Paterson
     
    18 Nucleic Acid Vaccination, 275
    Britta Wahren & Margaret A. Liu
     
    19 Artificial Antigen-presenting Cells: Large Multivalent Immunogens, 286
    Matthew F. Mescher & Julie M. Curtsinger
     
    Part 5 Delivery Systems
     
    20 Transcutaneous Immunization via Vaccine Patch Delivery System, 303
    Robert C. Seid, Jr & Gregory M. Glenn
     
    21 Needle-free Jet Injection for Vaccine Administration, 324
    Brian R. Sloat, Hoi K. Tran, & Zhengrong Cui
     
    22 Oral Vaccines: An Old Need and Some New Possibilities, 336
    Amit A. Lugade, Kalathil Suresh, & Yasmin Thanavala
     
    23 Adjuvants: From Serendipity to Rational Discovery, 348
    Derek T. O'Hagan & Andreas Wack
     
    24 Immunostimulatory Properties of Biodegradable Microparticles, 361
    Fiona A. Sharp & Ed C. Lavelle
     
    25 Co-administration of Co-stimulatory Moieties, 375
    Carolina Arancibia-C ´arcamo & Yvette Latchman
     
    26 Toll Receptors in Relation to Adjuvant Effects, 393
    Dipshikha Chakravortty, Amit Lahiri, & Priyanka Das
     
    Part 6 Regulatory Considerations
     
    27 Regulatory Issues (FDA and EMA), 403
    Murrium Ahmad, Victoria Byers, & Peter Wilson
     
    Part 7 Evaluating Vaccine Efficacy
     
    28 Immune Monitoring Design within the Developmental Pipeline for an Immunotherapeutic or Preventive Vaccine, 419
    Sylvia Janetzki, Pedro Romero, Mario Roederer, Diane L. Bolton, & Camilla Jandus
     
    29 Clinical Development Strategy: Nuts and Bolts, 441
    Candida Fratazzi & Claudio Carini
     
    30 Current Approaches to Identify and Evaluate Can